Literature DB >> 18511699

Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium.

Xuri Li1, Marc Tjwa, Inge Van Hove, Berndt Enholm, Elke Neven, Karri Paavonen, Michael Jeltsch, Toni Diez Juan, Richard E Sievers, Emmanuel Chorianopoulos, Hiromichi Wada, Maarten Vanwildemeersch, Agnes Noel, Jean-Michel Foidart, Matthew L Springer, Georges von Degenfeld, Mieke Dewerchin, Helen M Blau, Kari Alitalo, Ulf Eriksson, Peter Carmeliet, Lieve Moons.   

Abstract

OBJECTIVE: The endogenous role of the VEGF family member vascular endothelial growth factor-B (VEGF-B) in pathological angiogenesis remains unclear. METHODS AND
RESULTS: We studied the role of VEGF-B in various models of pathological angiogenesis using mice lacking VEGF-B (VEGF-B(-/-)) or overexpressing VEGF-B(167). After occlusion of the left coronary artery, VEGF-B deficiency impaired vessel growth in the ischemic myocardium whereas, in wild-type mice, VEGF-B(167) overexpression enhanced revascularization of the infarct and ischemic border zone. By contrast, VEGF-B deficiency did not affect vessel growth in the wounded skin, hypoxic lung, ischemic retina, or ischemic limb. Moreover, VEGF-B(167) overexpression failed to enhance vascular growth in the skin or ischemic limb.
CONCLUSIONS: VEGF-B appears to have a relatively restricted angiogenic activity in the ischemic heart. These insights might offer novel therapeutic opportunities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511699      PMCID: PMC2753879          DOI: 10.1161/ATVBAHA.107.158725

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  27 in total

Review 1.  VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis.

Authors:  Marc Tjwa; Aernout Luttun; Monica Autiero; Peter Carmeliet
Journal:  Cell Tissue Res       Date:  2003-09-10       Impact factor: 5.249

2.  Regulation of flt-1 expression during mouse embryogenesis suggests a role in the establishment of vascular endothelium.

Authors:  G H Fong; J Klingensmith; C R Wood; J Rossant; M L Breitman
Journal:  Dev Dyn       Date:  1996-09       Impact factor: 3.780

3.  Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia.

Authors:  D Bellomo; J P Headrick; G U Silins; C A Paterson; P S Thomas; M Gartside; A Mould; M M Cahill; I D Tonks; S M Grimmond; S Townson; C Wells; M Little; M C Cummings; N K Hayward; G F Kay
Journal:  Circ Res       Date:  2000-02-04       Impact factor: 17.367

4.  Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation.

Authors:  T Ikuta; H Ariga; K Matsumoto
Journal:  Genes Cells       Date:  2000-11       Impact factor: 1.891

5.  Cloning and characterization of a novel human gene related to vascular endothelial growth factor.

Authors:  S Grimmond; J Lagercrantz; C Drinkwater; G Silins; S Townson; P Pollock; D Gotley; E Carson; S Rakar; M Nordenskjöld; L Ward; N Hayward; G Weber
Journal:  Genome Res       Date:  1996-02       Impact factor: 9.043

6.  VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.

Authors:  Tuomas T Rissanen; Johanna E Markkanen; Marcin Gruchala; Tommi Heikura; Antti Puranen; Mikko I Kettunen; Ivana Kholová; Risto A Kauppinen; Marc G Achen; Steven A Stacker; Kari Alitalo; Seppo Ylä-Herttuala
Journal:  Circ Res       Date:  2003-04-24       Impact factor: 17.367

7.  Angiogenic responses of vascular endothelial growth factors in periadventitial tissue.

Authors:  Shalini Bhardwaj; Himadri Roy; Marcin Gruchala; Helena Viita; Ivana Kholova; Ilze Kokina; Marc G Achen; Steven A Stacker; Marja Hedman; Kari Alitalo; Seppo Ylä-Herttuala
Journal:  Hum Gene Ther       Date:  2003-10-10       Impact factor: 5.695

8.  Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice.

Authors:  Daniela Tirziu; Emmanuel Chorianopoulos; Karen L Moodie; Robert T Palac; Zhen W Zhuang; Marc Tjwa; Carmen Roncal; Ulf Eriksson; Qiangwei Fu; Arye Elfenbein; Amy E Hall; Peter Carmeliet; Lieve Moons; Michael Simons
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

9.  Vascular endothelial growth factor B, a novel growth factor for endothelial cells.

Authors:  B Olofsson; K Pajusola; A Kaipainen; G von Euler; V Joukov; O Saksela; A Orpana; R F Pettersson; K Alitalo; U Eriksson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

10.  Vascular endothelial growth factor-B promotes in vivo angiogenesis.

Authors:  Jean-Sébastien Silvestre; Radia Tamarat; Teni G Ebrahimian; Aude Le-Roux; Michel Clergue; Florence Emmanuel; Micheline Duriez; Bertrand Schwartz; Didier Branellec; Bernard I Lévy
Journal:  Circ Res       Date:  2003-06-12       Impact factor: 17.367

View more
  44 in total

1.  VEGF-B: a thing of beauty.

Authors:  Xuri Li
Journal:  Cell Res       Date:  2010-06-08       Impact factor: 25.617

Review 2.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis.

Authors:  Fan Zhang; Zhongshu Tang; Xu Hou; Johan Lennartsson; Yang Li; Alexander W Koch; Pierre Scotney; Chunsik Lee; Pachiappan Arjunan; Lijin Dong; Anil Kumar; Tuomas T Rissanen; Bin Wang; Nobuo Nagai; Pierre Fons; Robert Fariss; Yongqing Zhang; Eric Wawrousek; Ginger Tansey; James Raber; Guo-Hua Fong; Hao Ding; David A Greenberg; Kevin G Becker; Jean-Marc Herbert; Andrew Nash; Seppo Yla-Herttuala; Yihai Cao; Ryan J Watts; Xuri Li
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-06       Impact factor: 11.205

Review 4.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 5.  Receptor tyrosine kinase-mediated angiogenesis.

Authors:  Michael Jeltsch; Veli-Matti Leppänen; Pipsa Saharinen; Kari Alitalo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 6.  Tissue Engineering of the Microvasculature.

Authors:  Joe Tien
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

7.  VEGF-C and aortic cardiomyocytes guide coronary artery stem development.

Authors:  Heidi I Chen; Aruna Poduri; Harri Numi; Riikka Kivela; Pipsa Saharinen; Andrew S McKay; Brian Raftrey; Jared Churko; Xueying Tian; Bin Zhou; Joseph C Wu; Kari Alitalo; Kristy Red-Horse
Journal:  J Clin Invest       Date:  2014-10-01       Impact factor: 14.808

Review 8.  Endothelial fatty acid transport: role of vascular endothelial growth factor B.

Authors:  Carolina Hagberg; Annika Mehlem; Annelie Falkevall; Lars Muhl; Ulf Eriksson
Journal:  Physiology (Bethesda)       Date:  2013-03

9.  Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.

Authors:  Koen Poesen; Diether Lambrechts; Philip Van Damme; Joke Dhondt; Florian Bender; Nicolas Frank; Elke Bogaert; Bart Claes; Line Heylen; An Verheyen; Katrien Raes; Marc Tjwa; Ulf Eriksson; Masabumi Shibuya; Rony Nuydens; Ludo Van Den Bosch; Theo Meert; Rudi D'Hooge; Michael Sendtner; Wim Robberecht; Peter Carmeliet
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

10.  Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCγ-cPLA(2) activation and retinal neovascularization.

Authors:  Nikhlesh K Singh; Dale E Hansen; Venkatesh Kundumani-Sridharan; Gadiparthi N Rao
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.